Genes
NCBI Gene
One gene with its proteins, patents, drugs, trials, grants and papers.
85,013 comparisons from ClinicalTrials.gov.
Most participants first33,758 with no events in either group come last3,881 to 3,900 of 85,013
| Comparison | With the outcome | Risk difference, 95% interval | Participants | Trial |
|---|---|---|---|---|
| Arm 1: VAQTA™ vs Arm 2: VAQTA™ +ProQuad™: Participants With 1 or More Serious Vaccine-Related Adverse Experiences | 0 of 1,415 1 of 334 | -0.3 points -1.7 to 0.1 | 1,749 | NCT00326183 Hepatitis A Vaccine, Inactivated and Measles, Mumps, Rubella and Varicella Virus Vaccine Live Safety Study (V251-066)(COMPLETED) |
| Arm 1: VAQTA™ vs Arm 2: VAQTA™ +ProQuad™: Participants With 1 or More Systemic Adverse Experiences | 782 of 1,415 197 of 334 | -3.7 points -9.5 to 2.2 | 1,749 | NCT00326183 Hepatitis A Vaccine, Inactivated and Measles, Mumps, Rubella and Varicella Virus Vaccine Live Safety Study (V251-066)(COMPLETED) |
| CT Coronary Angiogram vs Standard Care: Invasive Coronary Angiography | 474 of 877 530 of 871 | -6.8 points -11.4 to -2.2 | 1,748 | NCT02284191 Rapid Assessment of Potential Ischaemic Heart Disease With CTCA |
| CT Coronary Angiogram vs Standard Care: Subsequent Non-fatal MI (Type 1 or 4b) | 35 of 877 38 of 871 | -0.4 points -2.3 to 1.5 | 1,748 | NCT02284191 Rapid Assessment of Potential Ischaemic Heart Disease With CTCA |
| CT Coronary Angiogram vs Standard Care: Coronary Revascularisation | 300 of 877 288 of 871 | 1.1 points -3.3 to 5.6 | 1,748 | NCT02284191 Rapid Assessment of Potential Ischaemic Heart Disease With CTCA |
| CT Coronary Angiogram vs Standard Care: Coronary Heart Disease Death | 11 of 877 6 of 871 | 0.6 points -0.4 to 1.6 | 1,748 | NCT02284191 Rapid Assessment of Potential Ischaemic Heart Disease With CTCA |
| CT Coronary Angiogram vs Standard Care: Discharged on Preventative Treatment or Alteration in Dosage of Preventative Treatment During Index Hospitalisation | 554 of 877 539 of 871 | 1.3 points -3.2 to 5.8 | 1,748 | NCT02284191 Rapid Assessment of Potential Ischaemic Heart Disease With CTCA |
| CT Coronary Angiogram vs Standard Care: Cardiovascular Disease Death or Subsequent Non-fatal MI | 48 of 877 46 of 871 | 0.2 points -2.0 to 2.3 | 1,748 | NCT02284191 Rapid Assessment of Potential Ischaemic Heart Disease With CTCA |
| CT Coronary Angiogram vs Standard Care: Coronary Heart Disease Death or Subsequent Non-fatal MI | 47 of 877 45 of 871 | 0.2 points -1.9 to 2.3 | 1,748 | NCT02284191 Rapid Assessment of Potential Ischaemic Heart Disease With CTCA |
| CT Coronary Angiogram vs Standard Care: Representation or Rehospitalisation With Suspected ACS/ Recurrent Chest Pain After Index Hospitalisation | 138 of 877 130 of 871 | 0.8 points -2.6 to 4.2 | 1,748 | NCT02284191 Rapid Assessment of Potential Ischaemic Heart Disease With CTCA |
| CT Coronary Angiogram vs Standard Care: All-cause Death or Subsequent Non-fatal Type 1 or Type 4b MI at One Year Measured as Time to First Such Event. | 51 of 877 53 of 871 | -0.3 points -2.5 to 2.0 | 1,748 | NCT02284191 Rapid Assessment of Potential Ischaemic Heart Disease With CTCA |
| CT Coronary Angiogram vs Standard Care: Cardiovascular Death | 12 of 877 8 of 871 | 0.4 points -0.6 to 1.6 | 1,748 | NCT02284191 Rapid Assessment of Potential Ischaemic Heart Disease With CTCA |
| CT Coronary Angiogram vs Standard Care: Percutaneous Coronary Intervention | 260 of 877 240 of 871 | 2.1 points -2.1 to 6.3 | 1,748 | NCT02284191 Rapid Assessment of Potential Ischaemic Heart Disease With CTCA |
| CT Coronary Angiogram vs Standard Care: Subsequent Non-fatal MI | 39 of 877 40 of 871 | -0.1 points -2.1 to 1.8 | 1,748 | NCT02284191 Rapid Assessment of Potential Ischaemic Heart Disease With CTCA |
| CT Coronary Angiogram vs Standard Care: Number of Patients Prescribed ACS Therapies During Index Hospitalisation | 595 of 877 580 of 871 | 1.3 points -3.1 to 5.6 | 1,748 | NCT02284191 Rapid Assessment of Potential Ischaemic Heart Disease With CTCA |
| CT Coronary Angiogram vs Standard Care: Coronary Artery Bypass Graft | 52 of 877 55 of 871 | -0.4 points -2.7 to 1.9 | 1,748 | NCT02284191 Rapid Assessment of Potential Ischaemic Heart Disease With CTCA |
| CT Coronary Angiogram vs Standard Care: Coronary Heart Disease (CHD) Death or Subsequent Non-fatal MI (Type 1 or 4b) | 43 of 877 43 of 871 | -0.0 points -2.1 to 2.0 | 1,748 | NCT02284191 Rapid Assessment of Potential Ischaemic Heart Disease With CTCA |
| CT Coronary Angiogram vs Standard Care: All-cause Death | 19 of 877 17 of 871 | 0.2 points -1.2 to 1.6 | 1,748 | NCT02284191 Rapid Assessment of Potential Ischaemic Heart Disease With CTCA |
| CT Coronary Angiogram vs Standard Care: Non-cardiovascular Death | 7 of 877 9 of 871 | -0.2 points -1.2 to 0.7 | 1,748 | NCT02284191 Rapid Assessment of Potential Ischaemic Heart Disease With CTCA |
| CT Coronary Angiogram vs Standard Care: deaths from any cause | 19 of 877 17 of 871 | 0.2 points -1.2 to 1.6 | 1,748 | NCT02284191 Rapid Assessment of Potential Ischaemic Heart Disease With CTCA |
Code
curl "https://conductscience.org/api/comparisons/v1?page=195"
Response
The first 2 of this page's 20 results. GET /api/comparisons/v1?page=195
{
"data": {
"total": 85013,
"results": [
{
"id": "NCT00326183-bdc1d47d",
"title": "Arm 1: VAQTA™ vs Arm 2: VAQTA™ +ProQuad™: Participants With 1 or More Serious Vaccine-Related Adverse Experiences",
"summary": "0 of 1415 against 1 of 334; risk difference -0.3 points, 95% interval -1.7 to 0.1; NCT00326183, Hepatitis A Vaccine, Inactivated and Measles, Mumps, Rubella and Varicella Virus Vaccine Live Safety Study (V251-066)(COMPLETED)",
"record": "/library/comparisons/NCT00326183-bdc1d47d",
"nct_id": "NCT00326183",
"kind": "outcome",
"participants": 1749,
"risk_difference": {
"value": -0.0029940119760479044,
"lower": -0.016761820499682663,
"upper": 0.0006676885955971788
},
"group_1": "0 of 1,415",
"group_2": "1 of 334",
"difference": "-0.3 points",
"interval": "-1.7 to 0.1",
"trial_title": "Hepatitis A Vaccine, Inactivated and Measles, Mumps, Rubella and Varicella Virus Vaccine Live Safety Study (V251-066)(COMPLETED)"
},
{
"id": "NCT00326183-be2c2a60",
"title": "Arm 1: VAQTA™ vs Arm 2: VAQTA™ +ProQuad™: Participants With 1 or More Systemic Adverse Experiences",
"summary": "782 of 1415 against 197 of 334; risk difference -3.7 points, 95% interval -9.5 to 2.2; NCT00326183, Hepatitis A Vaccine, Inactivated and Measles, Mumps, Rubella and Varicella Virus Vaccine Live Safety Study (V251-066)(COMPLETED)",
"record": "/library/comparisons/NCT00326183-be2c2a60",
"nct_id": "NCT00326183",
"kind": "outcome",
"participants": 1749,
"risk_difference": {
"value": -0.037170182602991986,
"lower": -0.09481238545603868,
"upper": 0.022177770475446106
},
"group_1": "782 of 1,415",
"group_2": "197 of 334",
"difference": "-3.7 points",
"interval": "-9.5 to 2.2",
"trial_title": "Hepatitis A Vaccine, Inactivated and Measles, Mumps, Rubella and Varicella Virus Vaccine Live Safety Study (V251-066)(COMPLETED)"
}
],
"no_events": 33758,
"columns": [
{
"key": "title",
"label": "Comparison"
},
{
"key": "group_1",
"label": "With the outcome",
"under": "group_2"
},
{
"key": "difference",
"label": "Risk difference, 95% interval",
"under": "interval"
},
{
"key": "participants",
"label": "Participants"
},
{
"key": "nct_id",
"label": "Trial",
"under": "trial_title"
}
],
"order": "Most participants first",
"kinds": {
"all": 85013,
"outcome": 33568,
"serious-adverse-events": 31897,
"deaths": 19548
}
},
"release": "trial-comparisons-2026-03-23-0.1.0",
"terms": [
{
"source": "ClinicalTrials.gov's posted results, through CTTI's AACT",
"license": "ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299",
"notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
"short": "Freely available. Acknowledgement requested"
},
{
"source": "ClinicalTrials.gov",
"license": "none stated",
"notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
"short": "No license stated"
}
],
"next": "/api/comparisons/v1?page=196",
"request_id": "8cuWizSVoow1I5JZ"
}Ask about these results. The first 10 go in the prompt.
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.
NCBI Gene
One gene with its proteins, patents, drugs, trials, grants and papers.
ClinicalTrials.gov
Search clinical trials by condition, drug, outcome or NCT number, with the results each one posted.
Patent publications
Paste a sequence and see the patents that disclose it.
Opens sequences.conductscience.org
For software
Every answer on this page is also JSON, under /api/comparisons/v1. No key.
GET https://conductscience.org/api/comparisons/v1?q=placebo%20heart%20failure&kind=outcome
Ask an assistant